| scholarly article | Q13442814 |
| P50 | author | Xianghuo He | Q39051788 |
| P2093 | author name string | Jinjun Li | |
| Ying Wang | |||
| Jie Ding | |||
| Yingjun Zhao | |||
| Qifeng Wang | |||
| Qi Tian | |||
| Chao Ge | |||
| Linhui Liang | |||
| Shenglin Huang | |||
| Ruopeng Zha | |||
| Taoyang Chen | |||
| Haibing Shi | |||
| P2860 | cites work | MicroRNAs modulate the noncanonical transcription factor NF-kappaB pathway by regulating expression of the kinase IKKalpha during macrophage differentiation | Q34079793 |
| Analysis of MiR-195 and MiR-497 expression, regulation and role in breast cancer | Q34166724 | ||
| miR-301a as an NF-κB activator in pancreatic cancer cells | Q34485753 | ||
| MicroRNA-223 is commonly repressed in hepatocellular carcinoma and potentiates expression of Stathmin1. | Q34786558 | ||
| MicroRNA-195 plays a tumor-suppressor role in human glioblastoma cells by targeting signaling pathways involved in cellular proliferation and invasion | Q35760644 | ||
| NF-kappaB-YY1-miR-29 regulatory circuitry in skeletal myogenesis and rhabdomyosarcoma | Q37311506 | ||
| IKK beta plays an essential role in the phosphorylation of RelA/p65 on serine 536 induced by lipopolysaccharide | Q40646108 | ||
| Silencing of hsa-miR-124 by EVI1 in cell lines and patients with acute myeloid leukemia. | Q42380741 | ||
| MicroRNA-195 suppresses tumorigenicity and regulates G1/S transition of human hepatocellular carcinoma cells. | Q44738304 | ||
| Direct Phosphorylation of IB by IKK and IKK: Discrimination Between Free and NF-B-Bound Substrate | Q55919356 | ||
| Chromosomal allelic imbalance evolving from liver cirrhosis to hepatocellular carcinoma | Q57205467 | ||
| Molecular and transcriptional characterization of 17p loss in B-cell chronic lymphocytic leukemia | Q60197192 | ||
| Identification of miRNomes in Human Liver and Hepatocellular Carcinoma Reveals miR-199a/b-3p as Therapeutic Target for Hepatocellular Carcinoma | Q61645725 | ||
| microRNA-195 promotes apoptosis and suppresses tumorigenicity of human colorectal cancer cells | Q84780931 | ||
| Identification of differentially expressed microRNAs in human male breast cancer | Q21261330 | ||
| TAB3, a new binding partner of the protein kinase TAK1 | Q24530663 | ||
| miR-15 and miR-16 induce apoptosis by targeting BCL2 | Q24536069 | ||
| Frequent deletions and down-regulation of micro- RNA genes miR15 and miR16 at 13q14 in chronic lymphocytic leukemia | Q24539231 | ||
| MicroRNA-29 family reverts aberrant methylation in lung cancer by targeting DNA methyltransferases 3A and 3B | Q24564757 | ||
| Identification of a human NF-kappaB-activating protein, TAB3 | Q24621651 | ||
| MicroRNAs in NF-kappaB signaling | Q24630097 | ||
| MiR-15a and MiR-16 control Bmi-1 expression in ovarian cancer | Q24632636 | ||
| Role of the TAB2-related protein TAB3 in IL-1 and TNF signaling | Q24633992 | ||
| A pleiotropically acting microRNA, miR-31, inhibits breast cancer metastasis | Q24649156 | ||
| Inflammation and cancer | Q24649640 | ||
| NF-kappaB-dependent induction of microRNA miR-146, an inhibitor targeted to signaling proteins of innate immune responses | Q24670080 | ||
| Acetylation of RelA at discrete sites regulates distinct nuclear functions of NF-kappaB. | Q28118359 | ||
| Duration of nuclear NF-kappaB action regulated by reversible acetylation | Q28215080 | ||
| miR-15a and miR-16 are implicated in cell cycle regulation in a Rb-dependent manner and are frequently deleted or down-regulated in non-small cell lung cancer | Q28249659 | ||
| The IkappaB kinase complex (IKK) contains two kinase subunits, IKKalpha and IKKbeta, necessary for IkappaB phosphorylation and NF-kappaB activation | Q28252726 | ||
| Introduction to NF-kappaB: players, pathways, perspectives | Q28271022 | ||
| miR-146a suppresses invasion of pancreatic cancer cells | Q28272101 | ||
| Signaling to NF-kappaB | Q29547844 | ||
| Nuclear factor-kappaB in cancer development and progression | Q29547879 | ||
| The contributions of hepatitis B virus and hepatitis C virus infections to cirrhosis and primary liver cancer worldwide | Q29616215 | ||
| Modulation of miR-155 and miR-125b levels following lipopolysaccharide/TNF-alpha stimulation and their possible roles in regulating the response to endotoxin shock | Q29619768 | ||
| Inducibility of kappa immunoglobulin enhancer-binding protein Nf-kappa B by a posttranslational mechanism | Q29619866 | ||
| Inflammation meets cancer, with NF-κB as the matchmaker | Q29620242 | ||
| Expression of microRNA-146 suppresses NF-kappaB activity with reduction of metastatic potential in breast cancer cells | Q33609716 | ||
| P433 | issue | 2 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | NF-κB | Q411114 |
| positive regulation of I-kappaB kinase/NF-kappaB signaling | Q14864035 | ||
| TNF | Q18032037 | ||
| TGF-beta activated kinase 1 (MAP3K7) binding protein 3 | Q21112827 | ||
| Component of inhibitor of nuclear factor kappa B kinase complex | Q21130508 | ||
| P304 | page(s) | 654-666 | |
| P577 | publication date | 2013-06-26 | |
| P1433 | published in | Hepatology | Q15724398 |
| P1476 | title | Genome-wide screening reveals that miR-195 targets the TNF-α/NF-κB pathway by down-regulating IκB kinase alpha and TAB3 in hepatocellular carcinoma | |
| P478 | volume | 58 |
| Q51433586 | A MicroRNA-Mediated Positive Feedback Regulatory Loop of the NF-κB Pathway in Litopenaeus vannamei. |
| Q34662934 | A meta-analysis of microRNA expression in liver cancer. |
| Q42223486 | Association of miRNA-122-binding site polymorphism at the interleukin-1 α gene and its interaction with hepatitis B virus mutations with hepatocellular carcinoma risk |
| Q34391443 | Cardio-miRNAs and onco-miRNAs: circulating miRNA-based diagnostics for non-cancerous and cancerous diseases |
| Q36955787 | Circulating inflamma-miRs in aging and age-related diseases |
| Q64102041 | Effects of triptolide on bone marrow-derived mesenchymal stem cells from patients with multiple myeloma |
| Q52676734 | Efficient targeted tumor imaging and secreted endostatin gene delivery by anti-CD105 immunoliposomes. |
| Q37514695 | Expression of Long Non-Coding RNA (lncRNA) Small Nucleolar RNA Host Gene 1 (SNHG1) Exacerbates Hepatocellular Carcinoma Through Suppressing miR-195. |
| Q55436667 | Expression of tumor suppressors miR-195 and let-7a as potential biomarkers of invasive breast cancer. |
| Q45039242 | Extracellular vesicles carry microRNA-195 to intrahepatic cholangiocarcinoma and improve survival in a rat model |
| Q57285344 | Genes interconnecting AMPK and TREM-1 and associated microRNAs in rotator cuff tendon injury |
| Q27324064 | Genome-wide screening identified that miR-134 acts as a metastasis suppressor by targeting integrin β1 in hepatocellular carcinoma |
| Q59355524 | Hepatocellular Carcinoma: Causes, Mechanism of Progression and Biomarkers |
| Q35927721 | Identification of a blood-borne miRNA signature of synovial sarcoma |
| Q41024459 | Identification of novel diagnostic and prognostic miRNA signatures in endometrial cancer |
| Q91951381 | Inflammation and Liver Cancer: Molecular Mechanisms and Therapeutic Targets |
| Q57173113 | Integrated analysis of a competing endogenous RNA network reveals key lncRNAs as potential prognostic biomarkers for human bladder cancer |
| Q36562147 | Interleukin 6 trigged ataxia-telangiectasia mutated activation facilitates lung cancer metastasis via MMP-3/MMP-13 up-regulation |
| Q28079138 | Involvement of inflammation and its related microRNAs in hepatocellular carcinoma |
| Q48265359 | LINC00473 antagonizes the tumour suppressor miR-195 to mediate the pathogenesis of Wilms tumour via IKKα. |
| Q55073980 | Long noncoding RNA miR503HG, a prognostic indicator, inhibits tumor metastasis by regulating the HNRNPA2B1/NF-κB pathway in hepatocellular carcinoma. |
| Q38195700 | Macro advances in microRNAs and myocardial regeneration |
| Q38823802 | MetastamiRs: A promising choice for antihepatocellular carcinoma nucleic acid drug development |
| Q38663358 | MiR-195 Inhibits Tumor Growth and Metastasis in Papillary Thyroid Carcinoma Cell Lines by Targeting CCND1 and FGF2. |
| Q35832394 | MiR-195 suppresses non-small cell lung cancer by targeting CHEK1. |
| Q42833552 | MiR-497∼195 cluster microRNAs regulate osteoblast differentiation by targeting BMP signaling |
| Q31152555 | MiR-525-3p enhances the migration and invasion of liver cancer cells by downregulating ZNF395. |
| Q35590504 | MicroRNA Screening and the Quest for Biologically Relevant Targets |
| Q36746243 | MicroRNA-127-5p targets the biliverdin reductase B/nuclear factor-κB pathway to suppress cell growth in hepatocellular carcinoma cells |
| Q58547821 | MicroRNA-195: a review of its role in cancers |
| Q37609283 | MicroRNA-26b suppresses the NF-κB signaling and enhances the chemosensitivity of hepatocellular carcinoma cells by targeting TAK1 and TAB3. |
| Q38995250 | MicroRNA-331-3p promotes proliferation and metastasis of hepatocellular carcinoma by targeting PH domain and leucine-rich repeat protein phosphatase |
| Q40312208 | MicroRNA-3570 Modulates the NF-κB Pathway in Teleost Fish by Targeting MyD88. |
| Q36413892 | MicroRNA-424 inhibits Akt3/E2F3 axis and tumor growth in hepatocellular carcinoma |
| Q35832148 | MicroRNAs in apoptosis, autophagy and necroptosis |
| Q26853284 | MicroRNAs: regulators of cancer metastasis and epithelial-mesenchymal transition (EMT) |
| Q38211357 | Molecular mechanisms of oncogene-induced inflammation and inflammation-sustained oncogene activation in gastrointestinal tumors: an under-appreciated symbiotic relationship |
| Q34374372 | NAFLD, NASH and liver cancer |
| Q53403349 | NF-κB signaling relieves negative regulation by miR-194 in hepatocellular carcinoma by suppressing the transcription factor HNF-1α. |
| Q39972498 | Plasma levels of increased miR-195-5p correlates with the sFLT-1 levels in preeclampsia |
| Q37591701 | Pro-inflammation NF-κB signaling triggers a positive feedback via enhancing cholesterol accumulation in liver cancer cells |
| Q35035810 | Profiling circulating microRNA expression in experimental sepsis using cecal ligation and puncture |
| Q47373917 | Protein complex scaffolding predicted as a prevalent function of long non-coding RNAs |
| Q90227113 | Proteomic Analysis of miR-195 and miR-497 Replacement Reveals Potential Candidates that Increase Sensitivity to Oxaliplatin in MSI/P53wt Colorectal Cancer Cells |
| Q92645330 | Role of lentivirus-mediated overexpression of SOCS3 in proliferation and apoptosis of fibroblasts-like synoviocytes in Lewis rats with adjuvant-induced rheumatoid arthritis |
| Q37596666 | Role of microRNAs in inflammation-associated liver cancer |
| Q89612188 | Small Nucleolar RNA Host Gene 1 (SNHG1) and Chromosome 2 Open Reading Frame 48 (C2orf48) as Potential Prognostic Signatures for Liver Cancer by Constructing Regulatory Networks |
| Q55401749 | Small but Heavy Role: MicroRNAs in Hepatocellular Carcinoma Progression. |
| Q49609663 | Staphylococcus Aureus Triggers Induction of MIR-15B-5P to Diminish DNA Repair and De-Regulate inflammatory Response in Diabetic Foot Ulcers. |
| Q37225680 | TAB3 O-GlcNAcylation promotes metastasis of triple negative breast cancer |
| Q90763713 | TAB3 upregulates PIM1 expression by directly activating the TAK1-STAT3 complex to promote colorectal cancer growth |
| Q47094149 | TAB3 upregulates Survivin expression to promote colorectal cancer invasion and metastasis by binding to the TAK1-TRAF6 complex |
| Q89848688 | TET1 is a Tumor Suppressor That Inhibits Papillary Thyroid Carcinoma Cell Migration and Invasion |
| Q38370368 | The Interplay between PP2A and microRNAs in Leukemia |
| Q27003050 | The genetic and epigenetic alterations in human hepatocellular carcinoma: a recent update |
| Q52670029 | The mRNA, miRNA and lncRNA networks in hepatocellular carcinoma: An integrative transcriptomic analysis from Gene Expression Omnibus. |
| Q36538693 | The protective or damaging effect of Tumor necrosis factor-α in acute liver injury is concentration-dependent |
| Q38164571 | The role of microRNAs in hepatocarcinogenesis: current knowledge and future prospects. |
| Q38800435 | Yin Yang 1-mediated epigenetic silencing of tumour-suppressive microRNAs activates nuclear factor-κB in hepatocellular carcinoma. |
| Q36244787 | miR-195 Inhibits Tumor Progression by Targeting RPS6KB1 in Human Prostate Cancer |
| Q49378623 | miR-195 inhibits cell proliferation and angiogenesis in human prostate cancer by downregulating PRR11 expression |
| Q33685465 | miR-195 inhibits cell proliferation via targeting AEG-1 in hepatocellular carcinoma |
| Q35291824 | miR-27b synergizes with anticancer drugs via p53 activation and CYP1B1 suppression. |
| Q36224101 | miR-958 inhibits Toll signaling and Drosomycin expression via direct targeting of Toll and Dif in Drosophila melanogaster |
Search more.